SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.88-1.2%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mudcat who wrote (26743)12/3/1998 4:53:00 PM
From: Henry Niman  Read Replies (2) of 32384
 
I said approval would be a slam dunk for Panretin. The FDA issued an approvable letter 9 days after the Panretin advisory committee meeting and LGND (and analysts) are projecting approval this month. Why do you think the FDA is giving LGND a hard time?

Do you think that ONTAK and Panretin will NOT be approved? The combined rec votes were 20-1 for approval (which I would put into the slam dunk category).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News